Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5322 ARTÍCULOS , VIENDO DEL 3136 AL 3150

Dalfampridine as a promising agent in the management of hereditary spastic paraplegia: A triple-blinded, randomized, placebo-controlled pilot trial

Selcuk Muhtaroglu F, Belgen Kaygisiz B, Usar Incirli S, Kahraman T.

J Clin Neurosci. 2023 Nov;117:136-142. doi: 10.1016/j.jocn.2023.09.026. Epub 2023 Oct 5.

A Unique Case of Sarcoid-associated Myelopathy Accompanied by Lung Cancer

Tadokoro K, Nakada Y, Sasaki R, Nakano Y, Yunoki T, Shin K, Taoka M, Ninomiya K, Nomura E, Takemoto M, Morihara R, Yamashita T.

Intern Med. 2023 Dec 1;62(23):3531-3535. doi: 10.2169/internalmedicine.0943-22. Epub 2023 Apr 14.

Case report: Hereditary spastic paraplegia with a novel homozygous mutation in ZFYVE26

Lai ZH, Liu XY, Song YY, Zhou HY, Zeng LL.

Front Neurol. 2023 Aug 23;14:1160110. doi: 10.3389/fneur.2023.1160110. eCollection 2023.

ENHANCE proof-of-concept three-arm randomized trial: effects of reaching training of the hemiparetic upper limb restricted to the spasticity-free elbow range

Levin MF, Berman S, Weiss N, Parmet Y, Baniña MC, Frenkel-Toledo S, Soroker N, Solomon JM, Liebermann DG.

Sci Rep. 2023 Dec 22;13(1):22934. doi: 10.1038/s41598-023-49974-6.

[Efficacy and mechanism of scalp acupuncture for spastic cerebral palsy]

Xu JB, Tong GL.

Zhongguo Zhen Jiu. 2023 Feb 12;43(2):163-9. doi: 10.13703/j.0255-2930.20220408-0001.

Causes and length of stay of readmission among individuals with traumatic spinal cord injury: a prospective observational cohort study

Franceschini M, Cecconi L, Bonavita J, Pournajaf S, Ferro S, Pagliacci MC; Italian SCI Study Group.

Spinal Cord. 2023 Jul;61(7):383-390. doi: 10.1038/s41393-023-00874-6. Epub 2023 Feb 25.

Effect of TCM rehabilitation program on activities of daily living in patients with post-stroke limb spasticity: An observational study

Zhu C, Qiu L, Sun W, Yang C, Cong D, Wang Y, Ji G.

Medicine (Baltimore). 2023 Nov 24;102(47):e36079. doi: 10.1097/MD.0000000000036079.

Clinical presentation of patients with lower limb spasticity undergoing routine treatment with botulinum toxin: baseline findings from an international observational study

Esquenazi A, Zorowitz RD, Ashford S, Maisonobe P, Page S, Jacinto J.

J Rehabil Med. 2023 Oct 5;55:jrm4257. doi: 10.2340/jrm.v55.4257.

Pneumomediastinum: A case report of baclofen toxicity

Zari Meidani F, Rahmati R, Ghorbankhani M, Reisi-Vanani V, Alavi Farzaneh B.

Int J Surg Case Rep. 2023 Oct;111:108901. doi: 10.1016/j.ijscr.2023.108901. Epub 2023 Oct 3.

Early versus late injections of Botulinumtoxin type A in post-stroke spastic movement disorder: A literature review

Wissel J, Ri S, Kivi A.

Toxicon. 2023 Jun 15;229:107150. doi: 10.1016/j.toxicon.2023.107150. Epub 2023 May 3.

A Randomized, Double-Blind, Active Control, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Liztox(®) versus Botox(®) in Post-Stroke Upper Limb Spasticity

Ye DH, Chun MH, Park YG, Paik NJ, Lee SU, Yoo SD, Kim DY.

Toxins (Basel). 2023 Dec 12;15(12):697. doi: 10.3390/toxins15120697.

Research progress in extracorporeal shock wave therapy for upper limb spasticity after stroke

Duan H, Lian Y, Jing Y, Xing J, Li Z.

Front Neurol. 2023 Feb 9;14:1121026. doi: 10.3389/fneur.2023.1121026. eCollection 2023.

Use of immersive virtual reality for stress reduction during botulinum toxin injection for spasticity (RVTOX): a study protocol of a randomised control trial

Bougeard M, Hauret I, Pelletier-Visa M, Plan-Paquet A, Givron P, Badin M, Pereira B, Lanhers C, Coudeyre E.

BMJ Open. 2023 Oct 30;13(10):e066726. doi: 10.1136/bmjopen-2022-066726.

A Patient with Cerebral Palsy Presents for Evaluation of Third Molar Pain

Risner-Bauman A, Robbins MR.

Dent Clin North Am. 2023 Oct;67(4):577-579. doi: 10.1016/j.cden.2023.05.023. Epub 2023 Jun 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias